Evidence map›Paper›PMID 33716501›Full record

ArticleInternational journal of chronic obstructive pulmonary disease

Association Between Statin Use and Exacerbation of Chronic Obstructive Pulmonary Disease Among Patients Receiving Corticosteroids.

Yi-Jen Huang, Senyeong Kao, Li-Ting Kao, Chih-Feng Chian, Chi-Hsiang Chung, Wu-Chien Chien, Kwua-Yun Wang

Open access · goldAbstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Extrapulmonary Comorbidities Associated with Chronic Obstructive Pulmonary Disease: A Review.International journal of chronic obstructive pulmonary disease · 2024
    Review
  2. Review
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Yi-Jen HuangGraduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.ORCID 0000-0001-9279-487X
Senyeong KaoGraduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
Li-Ting KaoGraduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.ORCID 0000-0003-0692-7408
Chih-Feng ChianDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Chi-Hsiang ChungSchool of Public Health, National Defense Medical Center, Taipei, Taiwan.ORCID 0000-0002-4576-9900
Wu-Chien Chien *Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.ORCID 0000-0002-3286-0780
Kwua-Yun Wang *Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
Tri-Service General Hospital · TWNational Defense Medical Center · TWTaipei Veterans General Hospital · TWUniversity of Kang Ning · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe role of statins as anti-inflammatory drugs in chronic obstructive pulmonary disease (COPD) is controversial. This study aimed to determine the efficacy of statins used with or without corticosteroids in COPD patients. PATIENTS AND

methodsThis was a retrospective cohort study and used the two million outpatients and inpatients in Taiwan's Longitudinal Health Insurance Database covering 2000 to 2015. A total of 92,460 patients were identified in this study. We divided COPD patients into four groups by auditing each patient's medication (statins used or not; corticosteroids used or not) and used Cox regression to analyze and compare the effects of statins in COPD patients with or without corticosteroids.

resultsIn terms of all COPD patients, our findings were consistent with previous studies showing that statins decreased COPD-related hospitalization and mortality rates. However, the beneficial effects were only observed in younger patients or those not taking corticosteroids in further analysis. Statins significantly decreased hospitalization and mortality rates in the non-corticosteroids groups. The hazard ratios increased with age and were not statistically significant for patients > 70 years old. Statins did not significantly decrease ED visits, hospitalization, and mortality in corticosteroids groups.

conclusionStatins decreased hospitalization and mortality rates in COPD patients not taking corticosteroids but were not efficacious in patients on corticosteroids therapy. Furthermore, the beneficial effects of statins gradually decreased with patient age. Based on the findings, statins used in COPD patients may need to consider the patient age and corticosteroids used or not.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsPulmonary Disease, Chronic ObstructiveAdrenal Cortex HormonesAgedHospitalizationHumansRetrospective StudiesAdrenal Cortex HormonesHydroxymethylglutaryl-CoA Reductase InhibitorsCOPDcorticosteroidsexacerbationmortalitystatins

Identifiers

PMID33716501
PMCPMC7944644
OpenAlexW3134458618

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.